Literature DB >> 23269989

Combining transarterial chemoembolization with radiofrequency ablation for hepatocellular carcinoma: one step forward?

Andrew X Zhu, Riad Salem.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23269989     DOI： 10.1200/JCO.2012.46.1897

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

Review 1.  Transcatheter embolization therapy in liver cancer: an update of clinical evidences.

Authors:  Yì-Xiáng J Wáng; Thierry De Baere; Jean-Marc Idée; Sébastien Ballet
Journal:  Chin J Cancer Res       Date:  2015-04       Impact factor: 5.087

2.  Comparison of combination therapies in the management of hepatocellular carcinoma: transarterial chemoembolization with radiofrequency ablation versus microwave ablation.

Authors:  Michael Ginsburg; Sean P Zivin; Kristen Wroblewski; Taral Doshi; Raj J Vasnani; Thuong G Van Ha
Journal:  J Vasc Interv Radiol       Date:  2014-12-18       Impact factor: 3.464

3.  Copper chelation by trientine dihydrochloride inhibits liver RFA-induced inflammatory responses in vivo.

Authors:  Ji-Ming Yin; Li-Bo Sun; Jia-Sheng Zheng; Xin-Xin Wang; De-Xi Chen; Ning Li
Journal:  Inflamm Res       Date:  2016-09-09       Impact factor: 4.575

4.  Tumor Noninvasive and Target Embolization Therapy Platform by Intravenous Injection Based on Acidic Microenvironment-Responsive Hyperbranched Poly(amino acid)s.

Authors:  Dedai Lu; Jiachen Wang; Yunfei Li; Yongyong Zhang; Lili Yu; Tingting Xu; Hongyun Guo; Yongdong Zhang; Xingdong Wang; Xiaoqi Wang; Gaojun Teng; Ziqiang Lei
Journal:  ACS Cent Sci       Date:  2020-10-15       Impact factor: 14.553

Review 5.  Thyroid Radiofrequency Ablation: Updates on Innovative Devices and Techniques.

Authors:  Hye Sun Park; Jung Hwan Baek; Auh Whan Park; Sae Rom Chung; Young Jun Choi; Jeong Hyun Lee
Journal:  Korean J Radiol       Date:  2017-05-19       Impact factor: 3.500
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.